LBO — POST ACUTE MEDICAL OF HAMMOND
IRR: 33.7% | MOIC: 4.27x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
33.7%
IRR
4.27x
MOIC
$3.7M
Entry EV
$10.0M
Exit EV
$1.9M
Equity Invested
Sources & Uses
S&UTotal · $3.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $1.4M | 38.8% | |
| Sub Debt | $0.4M | 9.7% | |
| Equity | $1.9M | 51.5% | |
| Enterprise Value | $3.6M | 97.1% | |
| Transaction Fees | $0.1M | 2.9% | |
| Total Uses | $3.7M | 100.0% |
Interpretation
INTAt 4.27x MOIC and 33.7% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $1.0M |
| Exit Ev | $10.0M |
| Net Debt At Exit | $1.8M |
| Equity At Exit | $8.2M |
| Equity Invested | $1.9M |
| Total Value Created | $6.3M |
| Value From Growth | $6.2M |
| Value From Multiple | $0.2M |
| Value From Deleveraging | 0.0% |